Bank Of Montreal 2seventy Bio, Inc. Transaction History

Bank Of Montreal

$192 Billion
Q1 2025

A detailed history of Bank Of Montreal transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 15,653 shares of TSVT stock, worth $78,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,653

Holding current value

$78,265

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 13, 2025	BUY	$2.3 - $4.96 $36,001 - $77,638	15,653 New	15,653 $77,000
Q1 2023 Jun 13, 2024	BUY	$9.21 - $14.98 $1.49 Million - $2.43 Million	162,148 New	162,148 $1.65 Million

Others Institutions Holding TSVT

# of Institutions

153

Shares Held

46.7M

Call Options Held

116K

Put Options Held

7.5K

Goldman Sachs Group Inc New York, NY

4.68M
Shares

$23.4 Million
0.0% of portfolio
Beryl Capital Management LLC Redondo Beach, CA

4.25M
Shares

$21.3 Million
8.75% of portfolio
Black Rock Inc. New York, NY

3.66M
Shares

$18.3 Million
0.0% of portfolio
Morgan Stanley New York, NY

2.97M
Shares

$14.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.82M
Shares

$14.1 Million
0.0% of portfolio

View Full List

About 2seventy bio, Inc.

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $189M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

More about TSVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account